Polymorphisms in genes encoding antioxidant enzymes (SOD2, CAT, GPx, TXNRD, SEPP1, SEP15 and SELS) and risk of chronic kidney disease in Japanese - Cross-sectional data from the J-MICC study

Journal of Clinical Biochemistry and Nutrition

Volumn 53, Issue 1, 2013, Pages 15-20

  Hishida, Asahi ^a   Okada, Rieko ^a   Naito, Mariko ^a   Morita, Emi ^a   Wakai, Kenji ^a   Hamajima, Nobuyuki ^a   Hosono, Satoyo ^b   Nanri, Hinako ^c   Turin, Tanvir Chowdhury ^d,e   Suzuki, Sadao ^f   Kuwabara, Kazuyo ^g   Mikami, Haruo ^h   Budhathoki, Sanjeev ⁱ   Watanabe, Isao ^j   Arisawa, Kokichi ^k   Kubo, Michiaki ^l   Tanaka, Hideo ^b  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b AICHI CANCER CENTER HOSPITAL   (Japan)

^c SAGA UNIVERSITY   (Japan)

^d SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^e UNIVERSITY OF CALGARY   (Canada)

^f NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^g KAGOSHIMA UNIVERSITY   (Japan)

^h CHIBA CANCER CENTER   (Japan)

ⁱ KYUSHU UNIVERSITY   (Japan)

^j KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^k UNIVERSITY OF TOKUSHIMA   (Japan)

^l RIKEN   (Japan)

more..

Author keywords

Antioxidant enzymes; Chronic kidney disease; Genetic predisposition to disease; Single nucleotide polymorphisms

Indexed keywords

ANTIOXIDANT;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; CROSS-SECTIONAL STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; GLOMERULUS FILTRATION RATE; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84881307412     PISSN: 09120009     EISSN: None     Source Type: Journal    
DOI: 10.3164/jcbn.13-17     Document Type: Article

References (35)

1. Yamamoto R, Kanazawa A, Shimizu T, et al. Association between atherosclerosis and newly classified chronic kidney disease stage for Japanese patients with type 2 diabetes. Diabetes Res Clin Pract 2009;84:39-45.
2. Iseki K. Chronic kidney disease in Japan from early predictions to current facts. Nephron Clin Pract 2008;110:c268-c272.
3. Ninomiya T, Kiyohara Y. Chronic kidney diseases and other diseases:1. Cardiovascular diseases [in Japanese]. Nihon Naika Gakkai Zasshi 2007;96:887-893.
4. Matsuo S, Yasuda Y, Imai E, Horio M. Current status of estimated glomerular filtration rate (eGFR) equations for Asians and an approach to create a common eGFR equation. Nephrology (Carlton) 2010;15(Suppl 2):45-48.
5. Wattanakit K, Folsom AR, Selvin E, Coresh J, Hirsch AT, Weatherley BD. Kidney function and risk of peripheral arterial disease: results from the Atherosclerosis Risk in Communities (ARIC) Study. J Am Soc Nephrol 2007;18:629-636.
6. Chade AR, Lerman A, Lerman LO. Kidney in early atherosclerosis. Hypertension 2005;45:1042-1049.
7. Del Vecchio L, Locatelli F, Carini M. What we know about oxidative stress in patients with chronic kidney disease on dialysis-clinical effects, potential treatment, and prevention. Semin Dial 2011;24:56-64.
8. Crawford A, Fassett RG, Geraghty DP, et al. Relationships between single nucleotide polymorphisms of antioxidant enzymes and disease. Gene 2012;501:89-103.
9. Yuzhalin AE, Kutikhin AG. Inherited variations in the SOD and GPX gene families and cancer risk. Free Radio Res 2012;46:581-599.
10. Hamajima N; J-MICC Study Group. The Japan Multi-Institutional Collaborative Cohort Study (J-MICC Study) to detect gene-environment interactions for cancer. Asian Pac J Cancer Prev 2007;8:317-323.
11. Wakai K, Hamajima N, Okada R, et al. J-MICC Study Group. Profile of participants and genotype distributions of 108 polymorphisms in a crosssectional study to elucidate associations between genotypes and lifestyle and clinical factors: a project in the Japan multi-institutional Collaborative Cohort (J-MICC) Study. J Epidemiol 2011;21:223-235.
12. Matsuo S, Imai E, Horio M, et al. Collaborators developing the Japanese equation for estimated GFR. Revised Equations for Estimated GFR From Serum Creatinine in Japan. Am J Kidney Dis 2009;53:982-992.
13. Ohnishi Y, Tanaka T, Ozaki K, Yamada R, Suzuki H, Nakamura Y. A highthroughput SNP typing system for genome-wide association studies. J Hum Genet 2001;46:471-477.
14. Budtz-Jørgensen E, Keiding N, Grandjean P, Weihe P. Confounder selection in environmental epidemiology: assessment of health effects of prenatal mercury exposure. Ann Epidemiol 2007;17:27-35.
15. Ito T, Inoue E, Kamatani N. Association test algorithm between a qualitative phenotype and a haplotype or haplotype set using simultaneous estimation of haplotype frequencies, diplotype configurations and diplotype-based penetrances. Genetics 2004;168:2339-2348.
16. Rojas-Rivera J, Ortiz A, Egido J. Antioxidants in kidney diseases: the impact of bardoxolone methyl. Int J Nephrol 2012;21714.
17. Oberg BP, McMenamin E, Lucas FL, et al. Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease. Kidney Int 2004;65:1009-1016.
18. Crawford A, Fassett RG, Coombes JS, et al. Relationship between antioxidant enzyme genotype and activity and kidney function: a case-control study. Clin Nephrol 2012;78:135-144.
19. Okada R, Wakai K, Naito M, et al. Pro-/anti-inflammatory cytokine gene polymorphisms and chronic kidney disease: a cross-sectional study. BMC Nephrol 2012;13:2.
20. Fukai T, Ushio-Fukai M. Superoxide dismutases: role in redox signaling, vascular function, and diseases. Antioxid Redox Signal 2011;15:1583-1606.
21. Miao L, St Clair DK. Regulation of superoxide dismutase genes: implications in disease. Free Radic Biol Med 2009;47:344-356.
22. Crawford A, Fassett RG, Coombes JS, et al. Glutathione peroxidase, superoxide dismutase and catalase genotypes and activities and the progression of chronic kidney disease. Nephrol Dial Transplant 2011;26:2806-2813.
23. Brigelius-Flohé R, Kipp A. Glutathione peroxidases in different stages of carcinogenesis. Biochim Biophys Acta 2009;1790:1555-1568.
24. Brigelius-Flohé R. Tissue-specific functions of individual glutathione peroxidases. Free Radic Biol Med 1999;27:951-965.
25. Rayman MP. Selenoproteins and human health: insights from epidemiological data. Biochim Biophys Acta 2009;1790:1533-1540.
26. Imai H, Hirao F, Sakamoto T, et al. Early embryonic lethality caused by targeted disruption of the mouse PHGPx gene. Biochem Biophys Res Commun 2003;305:278-286.
27. Yant LJ, Ran Q, Rao L, et al. The selenoprotein GPX4 is essential for mouse development and protects from radiation and oxidative damage insults. Free Radic Biol Med 2003;34:496-502.
28. Ghaly MS, Ghattas MH, Labib SM. Association of catalase gene polymorphisms with catalase activity and susceptibility to systemic lupus erythematosus in the Suez Canal area, Egypt. Lupus 2012;21:1244-1249.
29. Hebert-Schuster M, Fabre EE, Nivet-Antoine V. Catalase polymorphisms and metabolic diseases. Curr Opin Clin NutrMetab Care 2012;15:397-402.
30. Forsberg L, Lyrenäs L, De Faire U, Morgenstern R. A common functional C-T substitution polymorphism in the promoter region of the human catalase gene influences transcription factor binding, reporter gene transcription and is correlated to blood catalase levels. Free Radic Biol Med 2001;30:500-505.
31. Bastaki M, Huen K, Manzanillo P, et al. Genotype-activity relationship for Mn-superoxide dismutase, glutathione peroxidase 1 and catalase in humans. Pharmacogenet Genomics 2006;16:279-286.
32. Chen H, Yu M, Li M, et al. Polymorphic variations in manganese superoxide dismutase (MnSOD), glutathione peroxidase-1(GPX1), and catalase (CAT) contribute to elevated plasma triglyceride levels in Chinese patients with type 2 diabetes or diabetic cardiovascular disease. Mol Cell Biochem 2012;363:85-91.
33. Chelikani P, Fita I, Loewen PC. Diversity of structures and properties among catalases. Cell Mol Life Sci 2004;61:192-208.
34. Thompson P, Roe DJ, Fales L, et al. Design and baseline characteristics of participants in a phase III randomized trial of celecoxib and selenium for colorectal adenoma prevention. Cancer Prev Res (Phila) 2012;5:1381-1393.
35. Méplan C, Hughes DJ, Pardini B, et al. Genetic variants in selenoprotein genes increase risk of colorectal cancer. Carcinogenesis 2010;31:1074-1079.